Sulbactam EP Impurity E
 
		Product Description
CAT No.
				
									ALN-S026006								
				CAS No.
				
									76646-91-8								
				Mol. F.
				
									C8H9Br2NO5S								
				Mol. Wt.
				
									391								
				Stock
				
									Please Inquire								
				
										
							
										Product Overview
						
											
										
							
										Technical Data
						
											
										
							
										Reference
						
											
										
							
										RFQ
						
									
							
							
							Product Overview
			
						
									Chemical Name : (2S,5R)-6,6-Dibromo-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid 4,4-dioxide								
				
									Smiles : O=C([C@@H](C(C)(C)S([C@]1([H])C2(Br)Br)(=O)=O)N1C2=O)O								
				
									Inchi : InChI=1S/C8H10BrNO3S.K/c1-8(2)4(7(12)13)10-5(11)3(9)6(10)14-8;/h3-4,6H,1-2H3,(H,12,13);/p-1/t3-,4+,6-;/m1./s1								
				
									Synonym : Sulbactam USP Related Compound E ; 6,6-dibromopenicillanic acid sulfone								
				
							
							
							Technical Data
			
						
							
							
							Reference
			
						Simultaneous determination of ampicillin, cefoperazone, and sulbactam in pharmaceutical formulations by HPLC with u03b2u2010cyclodextrin stationary phase
									Taiu2010Li Tsouu00a0 Yuu2010Chuan Huangu00a0 Chiuu2010Wey Leeu00a0 Anu2010Rong Leeu00a0 Hsianu2010Jenn Wangu00a0 Suu2010Hwei ChennJournal of Separation Science Volume30, Issue15 October 2007 Pages 2407-2413								
				High-performance liquid chromatography for the simultaneous estimation of cefoperazone and sulbactam in rat plasma and its importance in therapeutic drug monitoring
									swati korake,abhishek pawar,sushank surywanshi, c. bothiraja,atmaram pawar – Int J Pharm Pharm Sci, Vol 12, Issue 10, 92-97 								
				Development and Validation of Stability Indicating HPLC Method for the Determination of Impurities in the Sterile Mixture of Cefoperazone and Sulbactam
									Ramu Ivaturi, Thuttagunta Manikya Sastry, Satyaveni Sunkara – Current Pharmaceutical Analysis 14(7)								
				
							
							
							RFQ
			
						
 
                             
                             
                             
                             
                            